How Ozempic could save America's health system

Contributing sentiments towards policy:

48% : PrEP, the drug that reduces the risk of contracting HIV, is broadly available, affordable, and covered by Medicaid.
47% : For Medicaid, the immediate cost implications of coverage are balanced against the substantial long-term savings from reduced treatment of obesity-related illnesses.
42% : Investment in preventative health now will save Medicaid (and ultimately Medicare) significant costs later.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.